(Q71956002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Antithrombotic Effects of Orally Active Synthetic Antagonist of Activated Factor X in Nonhuman Primates (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

coagulation factor x human

25 June 2024

main subject

1 reference

6

L A Harker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

4

S R Hanson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

3

U M Marzec

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

2

A B Kelly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

T. Yokoyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634464

25 June 2024

S. Kunitada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634464

25 June 2024

language of work or name

English

0 references

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.3.485

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

25 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

485-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

Characterization of a cDNA coding for human factor X

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Synthetic inhibitors of serine proteinases XIV.+) inhibition of Factor Xa by derivatives of benzamidine

25 June 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Gabexate mesylate inhibition of serine proteases: thermodynamic and computer-graphics analysis

25 June 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Synthetic inhibitors of bovine factor Xa and thrombin comparison of their anticoagulant efficiency

25 June 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis

25 June 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Degradation of a benzamidine-type synthetic inhibitor of coagulation enzymes in plasma of various species

25 June 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity

25 June 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS)

25 June 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons

25 June 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin

25 June 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

25 June 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

25 June 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Introduction to clotting in blood plasma

25 June 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

A player of many parts: the spotlight falls on thrombin's structure.

25 June 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

25 June 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.3.485

25 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634464%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference